Bioatla provides guidance on near-term milestones and plans to announce third quarter 2023 financial results and business update on november 7, 2023

San diego, oct. 10, 2023 (globe newswire) -- bioatla, inc. (nasdaq: bcab), a global clinical-stage biotechnology company focused on the development of conditionally active biologic (cab) antibody therapeutics for the treatment of solid tumors, today provided guidance on near-term milestones and announced that it plans to host a conference call and webcast on tuesday, november 7, 2023 at 4:30 p.m. et to discuss its financial results for the quarter ended september 30, 2023 and provide business highlights.
BCAB Ratings Summary
BCAB Quant Ranking